Nevada
|
91-2048978
|
(State
of Incorporation)
|
(IRS
Employer Identification No.)
|
PART
I. FINANCIAL INFORMATION
|
||
Item
1.
|
Financial
Statements
|
|
Condensed
Consolidated Balance Sheets:
|
||
March
31, 2007 (Unaudited) and December 31, 2006
|
3
|
|
Condensed
Consolidated Statements of Losses:
|
||
Three
months Ended March 31, 2007 and 2006 (Unaudited)
|
4
|
|
Condensed
Consolidated Statements of Cash Flows:
|
||
Three
months Ended March 31, 2007 and 2006 (Unaudited)
|
5
|
|
Notes
to Unaudited Condensed Consolidated Financial Information:
|
||
March
31, 2007
|
6-21
|
|
Item
2.
|
Management
Discussion and Analysis
|
22
|
Item
3.
|
Controls
and Procedures
|
16
|
PART
II. OTHER INFORMATION
|
||
Item
1.
|
Legal
Proceedings
|
17
|
Item
2.
|
Unregistered
Sales of Equity Securities and Use of Proceeds
|
18
|
Item
3.
|
Defaults
Upon Senior Securities
|
19
|
Item
4.
|
Submission
of Matters to a Vote of Security Holders
|
19
|
Item
5.
|
Other
Information
|
19
|
Item
6.
|
Exhibits
|
19
|
Signatures
|
20
|
CYBERLUX
CORPORATION
|
|||||||
CONDENSED
CONSOLIDATED BALANCE SHEETS
|
|||||||
(unaudited)
March
31,
2007
|
December
31,
2006
|
||||||
ASSETS
|
|||||||
Current
assets:
|
|||||||
Cash
& cash equivalents
|
$
|
26,533
|
$
|
395,812
|
|||
Accounts
receivable, net of allowance for doubtful accounts of
$23,502
|
60,660
|
177,085
|
|||||
Inventories,
net of allowance of $102,660
|
206,574
|
197,771
|
|||||
Other
current assets
|
11,819
|
22,232
|
|||||
Total
current assets
|
305,586
|
792,900
|
|||||
Property,
plant and equipment, net of accumulated depreciation of $147,399
and
$141,465, respectively
|
63,694
|
58,313
|
|||||
Other
assets
|
|||||||
Deposits
|
23,350
|
23,350
|
|||||
Patents
and development costs, net of accumulated amortization of $425,222
and
$293,750, respectively
|
3,549,752
|
2,294,224
|
|||||
Total
other assets
|
3,573,102
|
2,317,574
|
|||||
Total
Assets
|
$
|
3,942,382
|
$
|
3,168,787
|
|||
LIABILITIES
AND DEFICIENCY IN STOCKHOLDERS' EQUITY
|
|||||||
Current
liabilities:
|
|||||||
Accounts
payable
|
$
|
733,041
|
$
|
564,875
|
|||
Accrued
liabilities
|
1,791,826
|
1,694,220
|
|||||
Short-term
notes payable - related parties
|
520,162
|
454,162
|
|||||
Short-term
notes payable
|
21,292
|
47,399
|
|||||
Short-term
convertible notes payable
|
55,857
|
604,187
|
|||||
Total
current liabilities
|
3,122,178
|
3,364,843
|
|||||
Long-term
liabilities:
|
|||||||
Notes
payable
|
1,981,717
|
1,580,621
|
|||||
Derivative
liability relating to convertible debentures
|
6,448,614
|
8,201,086
|
|||||
Warrant
liability relating to convertible debentures
|
1,182,719
|
2,954,080
|
|||||
Total
long-term liabilities
|
9,613,050
|
12,735,787
|
|||||
Total
liabilities
|
12,735,228
|
16,100,630
|
|||||
Commitments
and Contingencies
|
|||||||
Series
A convertible preferred stock, $0.001 par value; 200 shares designated,
28.9806 and 38.9806 issued and outstanding as of March 31, 2007
and
December 31, 2006, respectively
|
144,900
|
194,900
|
|||||
DEFICIENCY
IN STOCKHOLDERS' EQUITY
|
|||||||
Class
B convertible preferred stock, $0.001 par value, 800,000 shares
designated; 800,000 shares issued and outstanding for March 31,
2007 and
December 31, 2006
|
800
|
800
|
|||||
Class
C convertible preferred stock, $0.001 par value, 700,000 shares
designated; 150,000 and 100,000 shares issued and outstanding for
March
31, 2007 and December 31, 2006, respectively
|
150
|
100
|
|||||
Common
stock, $0.001 par value, 700,000,000 shares authorized; 223,274,757
and
128,279,157 shares issued and outstanding as of March 31, 2007
and
December 31, 2006, respectively
|
223,275
|
128,279
|
|||||
Subscription
received
|
-
|
25,000
|
|||||
Additional
paid-in capital
|
14,251,703
|
12,186,420
|
|||||
Accumulated
deficit
|
(23,413,674
|
)
|
(25,467,342
|
)
|
|||
Deficiency
in stockholders' equity
|
(8,937,746
|
)
|
(13,126,743
|
)
|
|||
Total
liabilities and (deficiency) in stockholders' equity
|
$
|
3,942,382
|
$
|
3,168,787
|
CYBERLUX
CORPORATION
|
|||||||
CONDENSED
CONSOLIDATED STATEMENTS OF OPERATIONS
|
|||||||
(unaudited)
|
|||||||
Three
months ended March 31,
|
|||||||
2007
|
2006
|
||||||
REVENUE:
|
$
|
49,462
|
$
|
47,200
|
|||
Cost
of goods sold
|
(40,320
|
)
|
(53,687
|
)
|
|||
Gross
margin (loss)
|
9,141
|
(6,487
|
)
|
||||
OPERATING
EXPENSES:
|
|||||||
Depreciation
|
137,407
|
7,265
|
|||||
Research
and development
|
69,713
|
38,826
|
|||||
General
and administrative expenses
|
755,807
|
1,347,729
|
|||||
Total
operating expenses
|
962,927
|
1,393,820
|
|||||
NET
LOSS FROM OPERATIONS
|
(953,785
|
)
|
(1,400,307
|
)
|
|||
Other
income/(expense)
|
|||||||
Unrealized
gain (loss) relating to adjustment of derivative and warrant liability
to
fair value of underlying securities
|
3,523,832
|
2,323,186
|
|||||
Interest
expense
|
(527,800
|
)
|
(738,130
|
)
|
|||
Debt
acquisition costs
|
11,420
|
(6,487
|
)
|
||||
Net
income before provision for income taxes
|
2,053,667
|
178,262
|
|||||
Income
taxes (benefit)
|
-
|
-
|
|||||
INCOME
AVAILABLE TO COMMON STOCKHOLDERS
|
$
|
2,053,667
|
$
|
178,262
|
|||
Weighted
average number of common shares outstanding-basic
|
189,015,023
|
80,285,613
|
|||||
Weighted
average number of common shares outstanding-fully diluted
|
Note
A
|
Note
A
|
|||||
Income
per share-basic
|
$
|
0.01
|
$
|
0.00
|
|||
Loss
per share - fully diluted
|
Note
A
|
Note
A
|
|||||
Preferred
dividend
|
$
|
24,000
|
$
|
24,000
|
CYBERLUX,
INC
|
|||||||
CONDENSED
CONSOLIDATED STATEMENTS OF CASH FLOW
|
|||||||
(unaudited)
|
|||||||
Three
months ended March 31,
|
|||||||
2007
|
2006
|
||||||
CASH
FLOWS FROM OPERATING ACTIVITIES:
|
|||||||
Net income
available to common stockholders
|
$
|
2,053,667
|
$
|
178,262
|
|||
Adjustments
to reconcile net income to cash used in operating
activities
|
|||||||
Depreciation
|
5,934
|
7,265
|
|||||
Amortization
|
131,473
|
-
|
|||||
Common
stock issued in connection with services rendered
|
-
|
762,250
|
|||||
Common
stock issued in settlement of debt
|
-
|
31,655
|
|||||
Accretion
of convertible notes payable
|
401,096
|
367,196
|
|||||
Unrealized
(gain) loss on adjustment of derivative and warrant liability to
fair
value of underlying securities
|
(3,523,832
|
)
|
(2,323,186
|
)
|
|||
Impairment
loss on patent
|
-
|
-
|
|||||
(Increase)
decrease in:
|
|||||||
Accounts
receivable
|
116,425
|
(41,018
|
)
|
||||
Inventories
|
(8,803
|
)
|
161,039
|
||||
Prepaid
expenses and other assets
|
10,413
|
9,402
|
|||||
Deposits
|
-
|
-
|
|||||
Increase
(decrease) in:
|
|||||||
Accounts
payable
|
168,166
|
(306,071
|
)
|
||||
Accrued
liabilities
|
97,604
|
279,829
|
|||||
Net
cash (used in) operating activities
|
(547,856
|
)
|
(873,377
|
)
|
|||
CASH
FLOWS FROM INVESTING ACTIVITIES:
|
|||||||
Net
cash acquired in connection with acquisition of Hybrid Lighting
Technologies, Inc
|
150,000
|
-
|
|||||
Payments
towards patent rights
|
-
|
-
|
|||||
Acquisition
of fixed assets
|
(11,316
|
)
|
(7,093
|
)
|
|||
Net
cash provided by (used in) investing activities:
|
138,684
|
(7,093
|
)
|
||||
CASH
FLOWS FROM FINANCING ACTIVITIES:
|
|||||||
Net
proceeds from issuance of convertible debentures
|
-
|
460,000
|
|||||
Net
proceeds (payments) from borrowing on long term basis
|
(26,107
|
)
|
152,400
|
||||
Net
proceeds (payments) to notes payable, related parties
|
66,000
|
500
|
|||||
Net
cash provided by (used in) financing activities:
|
39,893
|
612,900
|
|||||
Net
increase (decrease) in cash and cash equivalents
|
(369,279
|
)
|
(267,570
|
)
|
|||
Cash
and cash equivalents at beginning of period
|
395,812
|
475,656
|
|||||
Cash
and cash equivalents at end of period
|
$
|
26,533
|
$
|
208,086
|
|||
Supplemental
disclosures:
|
|||||||
Interest
Paid
|
$
|
-
|
$
|
2,770
|
|||
Income
Taxes Paid
|
-
|
-
|
|||||
NON-CASH
INVESTING AND FINANCING ACTIVITIES:
|
|||||||
Unrealized
(gain) loss in adjustment of derivative and warrant liability to
fair
value of underlying securities
|
(3,523,832
|
)
|
(2,323,186
|
)
|
|||
Common
stock issued for services rendered
|
-
|
762,250
|
|||||
Common
stock issued in settlement of debt
|
-
|
31,655
|
Preferred
Stock issued:
|
$
|
2,520,000
|
||
Cash
received
|
$
|
250,000
|
||
Patents
received
|
2,270,000
|
|||
Liabilities
assumed
|
(
-
|
)
|
||
Net:
|
$
|
2,520,000
|
Common
stock issued:
|
$
|
768,500
|
||
Preferred
stock issued:
|
768,500
|
|||
Preferred
Stock issued:
|
$
|
1,537,000
|
||
Cash
received
|
$
|
150,000
|
||
Patents
received
|
1,387,000
|
|||
Liabilities
assumed
|
(
-
|
)
|
||
Net:
|
$
|
1,537,000
|
Three
Months Ended
March
31, 2007
|
Three
Months Ended
March
31, 2006
|
||||||
Net
income used in computing basic net income per share
|
$
|
2,053,667
|
$
|
178,262
|
|||
Impact
of assumed assumptions:
|
|||||||
Accretion
of convertible debenture charged to interest expense
|
401,096
|
367,196
|
|||||
Impact
of equity classified as liability:
|
|||||||
Gain
on warrant liability marked to fair value
|
(3,523,832
|
)
|
(2,323,186
|
)
|
|||
Net
loss in computing diluted net loss per share:
|
$
|
(1,069,069
|
)
|
(1,777,728
|
)
|
Description
|
Cost
|
Accumulated
amortization and
impairments
|
Net
carrying value at March
31, 2007
|
|||||||
Development
costs
|
$
|
293,750
|
$
|
293,750
|
$
|
-0-
|
||||
Patents
|
2,294,224
|
81,936
|
2,212,287
|
|||||||
Patents
|
1,387,000
|
49,536
|
1,337,464
|
|||||||
Total
|
$
|
3,974,974
|
$
|
425,222
|
$
|
3,549,752
|
March
31, 2007
|
|
December
31, 2006
|
|||||
10%
convertible note payable, unsecured and due September, 2003; accrued
and
unpaid interest due at maturity; Note holder has the option to convert
note principal together with accrued and unpaid interest to the Company’s
common stock at a rate of $0.50 per share. The Company is in violation
of
the loan covenants
|
$
|
2,500
|
$
|
2,500
|
|||
10%
convertible debenture, due two years from the date of the note with
interest payable quarterly during the life of the note. The note
is
convertible into the Company’s common stock at the lower of a) $0.72 or b)
50% (See note L) of the average of the three lowest intraday trading
prices for the common stock on a principal market for twenty days
before,
but not including, conversion date. The Company granted the note
holder a
security interest in substantially all of the Company’s assets and
intellectual property and registration rights. The Company is in
violation
of the loan covenants (see below)
|
53,357
|
601,687
|
|||||
10%
convertible debenture, due three years from date of the note with
interest
payable quarterly during the life of the note. The note is convertible
into the Company’s common stock at the lower of a) $0.03 or b) 50% (See
note L) of the average of the three lowest intraday trading prices
for the
common stock on a principal market for twenty days before, but not
including, conversion date. The Company granted the note holder a
security
interest in substantially all of the Company’s assets and intellectual
property and registration rights. The Company is in violation of
the loan
covenants (see below)
|
923,106
|
799,817
|
|||||
10%
convertible debenture, due October 2008 with interest payable quarterly
during the life of the note. The note is convertible into the Company’s
common stock at the lower of a) $0.6 or b) 50% (See note L) of the
average
of the three lowest intraday trading prices for the common stock
on a
principal market for twenty days before, but not including, conversion
date. The Company granted the note holder a security interest in
substantially all of the Company’s assets and intellectual property and
registration rights. The Company is in violation of the loan covenants
(see below)
|
382,100
|
316,347
|
|||||
8%
convertible debenture, due December 2008 with interest payable quarterly
during the life of the note. The note is convertible into the Company’s
common stock at the lower of a) $0.10 or b) 35% (See note L0 of the
average of the three lowest intraday trading prices for the common
stock
on a principal market for twenty days before, but not including,
conversion date. The Company granted the note holder a security interest
in substantially all of the Company’s assets and intellectual property and
registration rights (see below)
|
292,786
|
235,251
|
March
31, 2007
|
December
31, 2006
|
||||||
8%
convertible debenture, due March 2009 with interest payable quarterly
during the life of the note. The note is convertible into the Company’s
common stock at the lower of a)$0.10 or b) 55% (See note L)of the
average
of the three lowest intraday trading prices for the common stock
on a
principal market for twenty days before, but not including, conversion
date. The Company granted the note holder a security interest in
substantially all of the Company’s assets and intellectual property and
registration rights. (See below)
|
$
|
168,493
|
$
|
127,397
|
|||
6%
convertible debenture, due July 2009 with interest payable quarterly
during the life of the note. The note is convertible into the Company’s
common stock at the lower of a)$0.10 or b) 40% (See note L)of the
average
of the three lowest intraday trading prices for the common stock
on a
principal market for twenty days before, but not including, conversion
date. The Company granted the note holder a security interest in
substantially all of the Company’s assets and intellectual property and
registration rights. (See below)
|
112,329
|
71,233
|
|||||
6%
convertible debenture, due September 2009 with interest payable quarterly
during the life of the note. The note is convertible into the Company’s
common stock at the lower of a)$0.10 or b) 40% (See note L) of the
average
of the three lowest intraday trading prices for the common stock
on a
principal market for twenty days before, but not including, conversion
date. The Company granted the note holder a security interest in
substantially all of the Company’s assets and intellectual property and
registration rights. (See below)
|
47,561
|
24,548
|
|||||
6%
convertible debenture, due December 2009 with interest payable quarterly
during the life of the note. The note is convertible into the Company’s
common stock at the lower of a)$0.10 or b) 40% (See note L) of the
average
of the three lowest intraday trading prices for the common stock
on a
principal market for twenty days before, but not including, conversion
date. The Company granted the note holder a security interest in
substantially all of the Company’s assets and intellectual property and
registration rights. (See below)
|
55,342
|
6,028
|
|||||
2,037,574
|
2,184,808
|
||||||
Less:
current maturities
|
(55,857
|
)
|
(604,187
|
)
|
|||
Notes
payable and convertible debentures-long term portion
|
$
|
1,981,717
|
$
|
1,580,621
|
·
|
The
Company allocated the proceeds received between convertible debt
and
detachable warrants based upon the relative fair market values on
the
dates the proceeds were received.
|
·
|
Subsequent
to the initial recording, the increase in the fair value of the detachable
warrants, determined under the Black-Scholes option pricing formula
and
the increase in the intrinsic value of the embedded derivative in
the
conversion feature of the convertible debentures are accrued as
adjustments to the liabilities at March 31, 2007 and December 31,
2006,
respectively.
|
·
|
The
expense relating to the increase in the fair value of the Company’s stock
reflected in the change in the fair value of the warrants and derivatives
(noted above) is included as an other comprehensive income item of
an
unrealized gain or loss arising from convertible financing on the
Company’s balance sheet.
|
·
|
Accreted
principal of $2,035,074 and $2,182,308 as of March 31, 2007 and December
31, 2006, respectively.
|
March
31, 2007
|
December
31, 2006
|
||||||
Convertible
debentures
|
$
|
2,037,574
|
$
|
2,184,808
|
|||
Warrant
liability
|
1,112,503
|
2,759,307
|
|||||
Derivative
liability
|
6,448,614
|
8,201,086
|
|||||
9,598,691
|
13,145,201
|
||||||
Cumulative
adjustment of derivative and warrant liability to fair
value
|
(1,181,117
|
)
|
(4,580,393
|
)
|
|||
Cumulative
unrealized loss relating to conversion of convertible notes to common
shares charged to interest expense
|
(1,446,642
|
)
|
(898,313
|
)
|
|||
Cumulative
accretion of principal related to convertible debentures
|
(2,035,074
|
)
|
(2,182,308
|
)
|
|||
$
|
4,935,858
|
$
|
5,484,187
|
March
31,
2007 |
December
31,
2006 |
||||||
Fair
value of warrants relating to convertible debentures
|
$
|
1,112,503
|
$
|
2,759,305
|
|||
Fair
value of other outstanding warrants
|
70,216
|
194,775
|
|||||
Total
|
$
|
1,182,719
|
$
|
2,954,080
|
March
31,
2007 |
December
31,
2006 |
||||||
Note
payable, 24% interest per annum; due 90 days, secured by specific
accounts
receivables
|
$
|
21,292
|
$
|
47,399
|
March
31,
2007 |
December
31,
2006 |
||||||
Notes
payable, 12% per annum; due on demand; unsecured
|
$
|
168,245
|
$
|
102,245
|
|||
Notes
payable, 10% per annum, due on demand; unsecured
|
251,350
|
251,350
|
|||||
Notes
payable, 10% per annum, due on demand, convertible into the Company’s
common stock after March 2007 at a conversion rate of $0.02 per share,
unsecured
|
100,567
|
100,567
|
|||||
520,162
|
454,162
|
||||||
Less:
current maturities:
|
(520,162
|
)
|
(454,162
|
)
|
|||
Long
term portion:
|
$
|
-
|
$
|
-
|
·
|
Subsequent
to the initial recording, the increase or decrease in the fair value
of
the detachable warrants, determined under the Black- Scholes option
pricing formula, were accrued as adjustments to the liabilities until
their expiration in November 2006.
|
·
|
The
expense relating to the increase or decrease in the fair value of
the
Company's stock reflected in the change in the fair value of the
warrants
(noted above) is included as an other comprehensive income item of
an
unrealized gain or loss arising from convertible financing on the
Company's balance sheet.
|
Exercise
Price
|
Number
Outstanding
|
Warrants
Outstanding
Weighted
Average
Remaining
Contractual
Life
(years)
|
Weighted
Average
Exercise
price
|
Number
Exercisable
|
Warrants
Exercisable
Weighted
Average
Exercise
Price
|
$0.01
|
100,000
|
1.75
|
$0.01
|
100,000
|
$0.01
|
0.03
|
26,500,000
|
3.17
|
0.03
|
26,500,000
|
0.03
|
0.06
|
45,000,000
|
6.53
|
0.06
|
45,000,000
|
0.03
|
0.10
|
20,641,500
|
5.67
|
0.10
|
20,641,500
|
0.10
|
0.20
|
1,845,000
|
0.50
|
0.20
|
1,845,000
|
0.20
|
0.25
|
1,758,500
|
1.75
|
0.25
|
1,758,500
|
0.25
|
0.50
|
2,300,000
|
2.15
|
0.50
|
2,300,000
|
0.50
|
1.05
|
1,750,000
|
1.75
|
1.05
|
1,750,000
|
1.05
|
Number
of Shares
|
|
Weighted
Average
Price
Per Share
|
|||||
Outstanding
at December 31, 2005
|
48,431,128
|
|
$0.42
|
||||
Granted
|
68,750,000
|
0.07
|
|||||
Exercised
|
(100,000
|
)
|
(0.25
|
)
|
|||
Canceled
or expired
|
(17,186,128
|
)
|
(0.64
|
)
|
|||
Outstanding
at December 31, 2006
|
99,895,000
|
0.09
|
|||||
Granted
|
-
|
-
|
|||||
Exercised
|
-
|
-
|
|||||
Canceled
or expired
|
-
|
-
|
|||||
Outstanding
at March 31, 2007
|
99,895,000
|
0.09
|
Number
of warrants
|
purchase
price per share:
|
Term
(years)
|
||
1,000,000
|
$0.10
|
2.75
|
Options
Outstanding
|
Options
Exercisable
|
|||||||||||||||
Exercise
Prices
|
Number
Outstanding
|
Weighted
Average
Remaining
Contractual
Life
(Years)
|
Weighted
Average
Exercise
Price
|
Number
Exercisable
|
Weighted
Average
Exercise
Price
|
|||||||||||
$0.2125
|
2,000,000
|
6.71
|
|
$0.2125
|
2,000,000
|
|
$0.2125
|
|||||||||
0.2125
|
2,000,000
|
7.12
|
0.2125
|
2,000,000
|
0.2125
|
|||||||||||
0.022
|
20,500,000
|
9.62
|
0.022
|
20,500,000
|
0.022
|
|||||||||||
0.0295
|
4,000,000
|
8.10
|
0.0295
|
4,000,000
|
0.0295
|
|||||||||||
0.04
|
14,430,000
|
9.32
|
0.04
|
14,430,000
|
0.04
|
|||||||||||
0.10
|
9,502,307
|
7.01
|
0.10
|
9,502,307
|
0.10
|
Number
of Shares
|
Weighted
Average
Price
Per Share
|
||||||
Outstanding
at December 31, 2005
|
34,000,000
|
$
|
0.076
|
||||
Granted
|
34,930,000
|
0.029
|
|||||
Exercised
|
(16,497,693
|
)
|
0.037
|
||||
Canceled
or expired
|
-
|
-
|
|||||
Outstanding
at December 31, 2006
|
52,432,307
|
0.0562
|
|||||
Granted
|
-
|
-
|
|||||
Exercised
|
-
|
-
|
|||||
Canceled
or expired
|
-
|
-
|
|||||
Outstanding
at March 31, 2007
|
52,432,307
|
$
|
0.0562
|
2007
|
|
$43,127
|
||
2008
|
14,376
|
|||
2009
|
-
|
|||
2010
|
-
|
31.1
|
Certification
of Chief Executive Officer pursuant to Rule 13a-14 and Rule 15d-14(a),
promulgated under the Securities and Exchange Act of 1934, as
amended
|
31.2
|
Certification
of Chief Financial Officer pursuant to Rule 13a-14 and Rule 15d 14(a),
promulgated under the Securities and Exchange Act of 1934, as
amended
|
32.1
|
Certification
pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section
906 of
the Sarbanes-Oxley Act of 2002 (Chief Executive
Officer)
|
32.2
|
Certification
pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section
906 of
the Sarbanes-Oxley Act of 2002 (Chief Financial
Officer)
|
CYBERLUX CORPORATION | |
Date:
May 21, 2007
|
By: /s/
DONALD F. EVANS
|
|
Donald
F. Evans
|
|
Chief
Executive Officer (Principal Executive Officer) and Chairman of the
Board
of Directors
|
|
|
Date:
May 21, 2007
|
By:/s/
DAVID D. DOWNING
|
|
David
D. Downing
|
|
Chief
Financial Officer (Principal Financial Officer and Principal Accounting
Officer)
|